The Friday Roundup is a collection of five stories that you need to know about each week. From policy, to innovations, look to us to keep you up to date on what’s happening in the healthcare industry.
P&G to Acquire Merck Germany’s Consumer Health Unit
P&G will pay $4.2 billion for the acquisition which includes vitamin brands Femibion and Neurobion. Analysts say the move will help Merck focus on pharmaceuticals and escape competition from online retailers like Amazon of non-prescription products.
For P&G, the addition should help capture more sales in the Latin American and Asian markets.
Study Ties Traumatic Brain Injury with Parkinson’s
A study of military veterans with a mild traumatic brain injury found their risk for developing Parkinson’s increased by 56 percent. The researchers advise patients with a previous brain injury take precautions to prevent falling and be on the lookout for early signs of Parkinson’s disease.
The study further solidifies the idea that any traumatic brain injury increase the chance of any neurodegenerative disease, as those with any level of severity had a risk increase of 71 percent.
The FDA Wishes You a Happy 4/20
The FDA has approved the first marijuana-based product for the treatment of epilepsy. The drug is made from cannabidiol, also known as CBD oil and reduced seizures in patients by 40 percent.
The drug was approved for two rare forms of epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome. Both syndromes consist of multiple different seizure types that were not previously controllable with drugs on the market.
Who Are You Calling Small-Brained?
Scientists have implanted human brain cells into baby mice and they grew into a brain that was both rodent and human. For up to 233 days, fluorescent green human cells were observed by scientists through a plastic casing over the mouse’s head.
The growth is hopeful to scientists, as it poses a possible solution to injured brain tissue and also gives insight on how the brain develops.
Facebook Probably Knows if You’re Sick
In the wake of the Cambridge Analytica scandal, questions about the privacy of the data stored by Facebook continue to come. Earlier this month, it was revealed that one of Facebook’s secret projects was to obtain patient data from hospitals.
The idea was to combine hospital data with its own to create patient profiles and during Mark Zuckerberg’s congressional testimony he shared that Facebook does collect some medical data on users due to them being in peer support groups.
New at AngelMD
- Don’t miss the chance to invest in Sensulin.
- Looking for a new podcast for your playlist? Check out On Call with AngelMD on iTunes, our podcast exploring the intersection of finance, technology, and healthcare.
Stay on top of the latest developments at AngelMD: Sign up and you’ll be the first to hear about new startups, syndicates, and events in your area.
The AngelMD Newsletter has the stories you need to know.
Image Credit: AngelMD